Taken together, our data suggest a critical contribution of ECM proteins to the resistance of HNSCC cells to PI3Kα inhibition and conventional radio(chemo)therapy with β1 integrin/Grb2 as a putative key part of the adaptation mechanism. The gene discussed is GRB2; the disease is head and neck squamous cell carcinoma.